Professor Chris Thiemermann

Professor of Pharmacology, Centre Lead for Translational Medicine & Therapeutics

Chris Thiemermann is the co-lead of the Organ Dysfunction and Protection Research Theme (together with Professor Karim Brohi) within the C4TS. Chris is Professor of Pharmacology and Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute (WHRI) and has 30 years’ experience in sepsis/traumatic shock research.

Supervision

(1) Role of IKK in the activation of NF-kB in sepsis, trauma and acute kidney injury; 

(2) Gender-differences in the response to sepsis and trauma; 

(3) Aging and response to tissue injury and shock; 

(4) Development of translatable interventions aimed at reducing the organ injury/dysfunction in trauma.

Research interests:

Chris has expertise in target discovery and evaluation of the efficacy of drugs in animal models of disease. His specific field of interest encompasses the pathophysiology of shock caused by trauma or sepsis, and reperfusion injury following ischemia (i.e. a restriction in blood supply to tissues, causing a shortage of oxygen and glucose needed to keep tissue alive). Hi research focuses upon the discovery of novel therapeutic targets and interventions that can be translated from the laboratory models of these diseases into the clinic for protection against associated organ injury.

Other research interests include the pathophysiology and treatment of (a) acute and chronic kidney disease and (b) acute myocardial infarction. Chris Thiemermann's lead role within the Organ Failure and Protection Research Theme aligns closely with his research at the William Harvey Research Institute (WHRI). To visit the WHRI's website click here.

Contact

email: c.thiemermann@qmul.ac.uk
Tel: +44 (0) 207 882 2121

    Share this page